Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer by Al B Benson, Anirban Maitra, Milind Javle, Michael Overman, Richard E Davis, Pankaj Vats, Chandan Kumar-Sinha, Lianchun Xiao, Niharika B Mettu, Edwin R Parra, Charles D Lopez, Veerendra Munugalavadla, Priti Patel, Lin Tao, Sattva Neelapu

Get full text

Neoadjuvant Multiagent Systemic Therapy Approach to Liver Transplantation for Perihilar Cholangiocarcinoma by Nadine Soliman, MD, Ashton A. Connor, MD, PhD, Ashish Saharia, MD, Sudha Kodali, MD, MSPH, Ahmed Elaileh, MD, Khush Patel, MD, MS, Samar Semaan, MD, Tamneet Basra, MD, David W. Victor, III, MD, Caroline J. Simon, MD, Yee Lee Cheah, MD, Mark J. Hobeika, MD, Constance M. Mobley, MD, PhD, Mukul Divatia, MD, Sadhna Dhingra, MD, Mary Schwartz, MD, Anaum Maqsood, MD, Kirk Heyne, MD, Maen Abdelrahim, MD, PhD, Milind Javle, MD, Jean-Nicolas Vauthey, MD, A. Osama Gaber, MD, R. Mark Ghobrial, MD, PhD

Get full text